Telemedicine screening for glaucoma detection
Glaucoma Telemedicine Screening
University Hospital Olomouc · NCT05446363
This study is testing a new way to find glaucoma in people living in rural areas of the Czech Republic by using telemedicine tools at local doctor's offices.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital Olomouc (other) |
| Locations | 1 site (Postřelmov) |
| Trial ID | NCT05446363 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance the detection of glaucoma in rural areas of the Czech Republic by utilizing teleophthalmology. It involves the use of a mobile fundus camera and intraocular tonometer in general practitioners' offices to identify patients at risk for glaucoma. Patients will be stratified into groups based on their intraocular pressure and optic disc status. The study also aims to detect other retinal pathologies as secondary outcomes, with evaluations conducted by specialists at the University Hospital Olomouc.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who can provide informed consent.
Not a fit: Patients who are unable to provide informed consent or who do not have access to the telemedicine technology may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to earlier detection and treatment of glaucoma, improving patient outcomes and reducing healthcare costs.
How similar studies have performed: Other studies have shown promise in using telemedicine for screening various conditions, suggesting potential success for this approach in glaucoma detection.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥ 18 years of age * Informed written and verbal consent Exclusion Criteria: • Absence of collaboration (informed consent)
Where this trial is running
Postřelmov
- Ordinace Pospíšil — Postřelmov, Czechia (RECRUITING)
Study contacts
- Study coordinator: Ladislav Stanke, Ph.D.
- Email: ladislav.stanke@fnol.cz
- Phone: +420 588 443 713
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Glaucoma